Table 2. Unadjusted associations of clinician characteristics and pathologic variables and the recommendation for adjuvant radiotherapy.

	Overall*		Urology		Radiation Oncology
	Relative Risk (95% CI)	p-value	Relative Risk (95% CI)	p-value	Relative Risk (95% CI)	p-value
Age (n = 127)
30-39 (ref.)	1.0	-	1.0	-	1.0	-
40-49	1.17 (1.06-1.28)	0.001	1.14 (0.99-1.31)	0.09	1.07 (0.96-1.18)	0.20
50-59	0.98 (0.88-1.10)	0.78	0.97 (0.83-1.13)	0.70	1.19 (1.08-1.31)	0.0007
≥60	0.86 (0.74-0.99)	0.05	0.92 (0.76-1.12)	0.42	0.72 (0.55-0.95)	0.02
Fellowship Training
(n = 127)
Yes vs. No	0.94 (0.86-1.02)	0.11	0.77 (0.67-0.89)	0.0003	0.92 (0.84-1.0)	0.05
Gleason score
(n = 128)
7 vs.6	1.38 (1.20-1.59)	<0.0001	1.60 (1.29-1.98)	<0.0001	1.16 (1.0-1.34)	0.05
8-10 vs. 6	1.81 (1.60-2.05)	<0.0001	2.33 (1.92-2.82)	<0.0001	1.30 (1.14-1.49)	<0.0001
8-10 vs. 7	1.31 (1.19-1.44)	<0.0001	1.45 (1.26-1.67)	<0.0001	1.13 (1.0-1.25)	0.03
Surgical Margin
(n =129)
R1 vs. R0	1.35 (1.23-1.48)	<0.0001	1.60 (1.39-1.85)	<0.0001	1.08 (0.99-1.19)	0.1
Stage (n = 129)
3a vs. 2	1.09 (0.98-1.26)	0.10	1.14 (0.98-1.32)	0.09	1.03 (0.92-1.15)	0.63
3b vs. 2	1.35 (1.21-1.50)	<0.0001	1.48 (1.27-1.74)	<0.0001	1.19 (1.06-1.32)	0.002
3b vs. 3a	1.24 (1.14-1.35)	<0.0001	1.31 (1.16-1.47)	<0.0001	1.16 (1.06-1.26)	0.0007
Practice Setting
(n = 127)
Community vs. Academic	0.84 (0.77-0.91)	<0.0001	1.07 (0.95-1.20)	0.29	0.95 (0.79-1.14)	0.56
Access to Radiotherapy
(n = 129)
Excellent vs. Poor/average	1.04 (0.93-1.15)	0.50	1.16 (0.98-1.37)	0.08	0.89 (0.82-0.97)	0.01

^* 10 respondents did not provide specialty information